Skip to Main Content
MRKR

Marker Therapeutics, Inc.

1.22 USD
-0.02 (-1.61%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Marker Therapeutics, Inc. stock is up 7.02% since 30 days ago. The next earnings date is Nov 12, 2026. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 22.22% of the previous 28 September’s closed higher than August.

  • Benzinga Insights
    Gainers Alector (NASDAQ:ALEC) shares increased by 9.7% to $2.59 during Tuesday's after-market session. The company's market cap stands at $256.8 million. NeuroSense Therapeutics (NASDAQ:NRSN) shares increased
  • Benzinga Newsdesk
    Marker Therapeutics (NASDAQ:MRKR) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.18) by 11.11 percent. This is a 60 percent increase over losses of $(0.40) per share from